As the population ages, it is likely that increasing numbers of LRRK2 relatives will develop Parkinson’s disease as a result of LRRK2 mutations, and the prevalence of this form of Parkinson’s disease will increase in the UK. This evidence concerns the gene LRRK2 and Parkinson disease.